IN-N01

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIN-N01
Drug Alias Namebeta-amyloid-specific humanized monoclonal antibodies (Intellect Neurosciences/IBL)IN-N01ANTISENILIN
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBeta amyloid A4 protein inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsMacular DegenerationGlaucomaAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmuno-Biological Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuno-Biological LaboratoriesIntellect Neurosciences
Active IndicationsN/A
Inactive IndicationsMacular DegenerationGlaucomaAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A